MA21323A1 - Dihydrate d'azithromycine et son procede de preparation. - Google Patents

Dihydrate d'azithromycine et son procede de preparation.

Info

Publication number
MA21323A1
MA21323A1 MA21565A MA21565A MA21323A1 MA 21323 A1 MA21323 A1 MA 21323A1 MA 21565 A MA21565 A MA 21565A MA 21565 A MA21565 A MA 21565A MA 21323 A1 MA21323 A1 MA 21323A1
Authority
MA
Morocco
Prior art keywords
preparing
same
azithromycin dihydrate
azithromycin
dihydrate
Prior art date
Application number
MA21565A
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
Kevin Michael Nepveux
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22202456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA21323(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of MA21323A1 publication Critical patent/MA21323A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA21565A 1987-07-09 1988-07-11 Dihydrate d'azithromycine et son procede de preparation. MA21323A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001612 WO1989000576A1 (fr) 1987-07-09 1987-07-09 Dihydrate d'azithromycine

Publications (1)

Publication Number Publication Date
MA21323A1 true MA21323A1 (fr) 1989-04-01

Family

ID=22202456

Family Applications (1)

Application Number Title Priority Date Filing Date
MA21565A MA21323A1 (fr) 1987-07-09 1988-07-11 Dihydrate d'azithromycine et son procede de preparation.

Country Status (45)

Country Link
US (1) US6268489B1 (fr)
EP (1) EP0298650B1 (fr)
JP (1) JPH0631300B2 (fr)
KR (1) KR900006218B1 (fr)
CN (1) CN1016785B (fr)
AP (1) AP44A (fr)
AR (1) AR243532A1 (fr)
AT (1) ATE72446T1 (fr)
AU (1) AU604553B2 (fr)
BA (1) BA98213B1 (fr)
BG (1) BG47348A3 (fr)
CA (1) CA1314876C (fr)
CS (1) CS272241B2 (fr)
CY (1) CY1776A (fr)
DD (1) DD271705A5 (fr)
DE (1) DE3868296D1 (fr)
DK (1) DK172573B1 (fr)
EG (1) EG18527A (fr)
ES (1) ES2038756T3 (fr)
FI (1) FI91263C (fr)
GR (1) GR3003737T3 (fr)
HK (1) HK127594A (fr)
HU (1) HU211862A9 (fr)
IE (1) IE60354B1 (fr)
IL (1) IL86979A (fr)
IN (1) IN168879B (fr)
IS (1) IS1540B (fr)
LV (1) LV10624B (fr)
MA (1) MA21323A1 (fr)
MX (1) MX12213A (fr)
MY (1) MY103744A (fr)
NO (1) NO171556C (fr)
NZ (1) NZ225338A (fr)
OA (1) OA08743A (fr)
PH (1) PH30953A (fr)
PL (1) PL157145B1 (fr)
PT (1) PT87933B (fr)
RO (1) RO107257B1 (fr)
RU (1) RU2066324C1 (fr)
SG (1) SG27794G (fr)
SI (1) SI8811325A8 (fr)
UA (1) UA27040C2 (fr)
WO (1) WO1989000576A1 (fr)
YU (1) YU45075B (fr)
ZA (1) ZA884925B (fr)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
EP0539223A1 (fr) * 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Tétrahydrate d'un sel monosodique d'un dérivé de glycine ayant un effet inhibiteur sur l'élastase
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
CN1034734C (zh) * 1993-12-10 1997-04-30 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
EP0758244B2 (fr) * 1994-05-06 2008-02-13 Pfizer Inc. Formes galeniques a liberation controlee de l'azithromycine
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT1437359E (pt) * 1997-10-16 2007-04-30 Glaxosmithkline Zagreb Novos 3,6-hemicetais da classe dos 9a-azalidos
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (fr) 1998-08-21 2002-01-29 Apotex Inc. Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention
JP2002531409A (ja) * 1998-11-30 2002-09-24 テバ ファーマシューティカル インダストリーズ リミティド アジスロマイシンのエタノール付加物、その製造方法、及びその医薬製剤
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
EP1189912B1 (fr) * 1999-05-18 2008-04-16 Pfizer Products Inc. Nouvelles formes cristallines d'un macrolide
ATE469910T1 (de) 1999-06-29 2010-06-15 Sandoz Ag Azithromycinmonohydrat
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
AU2928701A (en) * 2000-01-04 2001-07-16 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
ATE320441T1 (de) 2000-07-25 2006-04-15 Silanes Sa De Cv Lab Einstufiges verfahren zur herstellung von 7,16-
ES2172417B1 (es) * 2000-07-31 2003-09-16 Sint Quimica Sa Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
CA2429639C (fr) * 2000-11-27 2009-07-14 Biochemie S.A. Monohydrate d'azithromycine stable
RU2279439C2 (ru) * 2000-11-27 2006-07-10 Сандоз Аг Азитромицин в форме моногидрата и способ его получения
IN190080B (fr) * 2001-01-29 2003-06-07 Alembic Ltd
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1671979B1 (fr) 2001-05-22 2008-08-13 Pfizer Products Inc. Nouvelle forme cristalline de l'azithromycine
IL158591A0 (en) * 2001-05-22 2004-05-12 Pfizer Prod Inc Crystal forms of azithromycin
HRP20040163A2 (en) * 2001-08-21 2005-02-28 Pfizer Products Inc. Single dose azithromycin for treating respiratory infections
EP1455757A2 (fr) * 2001-12-21 2004-09-15 Pfizer Products Inc. Procedes de granulation par voie humide d'azithromycine
IL161996A0 (en) * 2001-12-21 2005-11-20 Pfizer Prod Inc Directly compressible formulations of azithromycin
BR0307331A (pt) * 2002-02-01 2004-12-07 Pfizer Prod Inc Formulações granuladas a seco de azitromicina
US7376064B2 (en) 2002-02-25 2008-05-20 Samsung Electronics Co., Ltd. Method and apparatus for recording data on optical recording medium
ITMI20021209A1 (it) * 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza
US6855813B2 (en) * 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB2395482A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Process for preparing non-hygroscopic azithromycin dihydrate
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
WO2005053639A2 (fr) * 2003-12-04 2005-06-16 Pfizer Products Inc. Formes multiparticulaires a liberation controlee produites avec des optimiseurs de dissolution
WO2005053652A1 (fr) 2003-12-04 2005-06-16 Pfizer Products Inc. Compositions medicamenteuses cristallines multiparticulaires contenant un poloxamere et un glyceride
JP2007513145A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
CA2549225A1 (fr) * 2003-12-04 2005-06-16 Pfizer Products Inc. Procede d'atomisation/congelation faisant appel a une extrudeuse pour la preparation de compositions medicamenteuses cristallines multiparticulaires contenant de preference un poloxamere et un glyceride
JP2007513143A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押出機を使用して好ましくはポロクサマーおよびグリセリドを含む多粒子アジスロマイシン組成物を製造するための噴霧凝固法
CA2547239A1 (fr) * 2003-12-04 2005-06-16 Pfizer Products Inc. Formes posologiques multiparticulaires d'azithromycine obtenues par des procedes se deroulant en milieu liquide
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
RU2260012C1 (ru) * 2004-01-29 2005-09-10 Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" Способ кристаллизации азитромицина дигидрата
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7235646B2 (en) 2004-06-28 2007-06-26 Alembic Limited Process for the preparation of azithromycin monohydrate isopropanol clathrate
CN1308361C (zh) * 2004-08-09 2007-04-04 大连振邦氟涂料股份有限公司 乙烯－三氟氯乙烯共聚物的制备方法
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
CA2584358A1 (fr) * 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoeruen Mukoedo Reszvenytarsasag Pimecrolimus amorphe non hygroscopique pulverulent
JP2008524317A (ja) * 2004-12-21 2008-07-10 ファイザー・プロダクツ・インク 腸溶コーティングされたアジスロマイシン多粒子
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN100366686C (zh) * 2006-01-12 2008-02-06 济南瑞氟化工科技有限公司 一种氟硅超双疏不粘涂料
EP2023721A2 (fr) * 2006-06-05 2009-02-18 Auspex Pharmaceuticals Inc. Préparation et utilité d'analogues d'érythromycine substitués
US7704959B2 (en) 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
US20090062220A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched azithromycin
CN101177441B (zh) * 2007-12-05 2012-05-23 浙江耐司康药业有限公司 一种稳定的阿奇霉素一水合物结晶的制备方法
CN101624412B (zh) 2008-07-10 2012-07-04 刘力 大环内酯类衍生物及其制备和用途
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
CA2739897C (fr) 2008-10-07 2017-10-03 Mpex Pharmaceuticals, Inc. Formulations a base de fluoroquinolone sous forme d'aerosol pour une pharmacocinetique amelioree
CN101418026B (zh) * 2008-10-09 2011-05-18 南京工业大学 一种晶型和粒度可控的阿奇霉素结晶工艺
CN101787063B (zh) * 2009-01-23 2012-12-19 刘力 抗感染药物及其制备和用途
US20120058936A1 (en) 2009-03-13 2012-03-08 Assistance Publique - Hopitaux De Paris Compositions and methods for elimination of gram negative bacteria
DK2473170T3 (da) 2009-09-04 2019-08-12 Horizon Orphan Llc Anvendelse af aerosoliseret levofloxacin til behandling af cystisk fibrose
CN102911219A (zh) * 2011-08-03 2013-02-06 山东方明药业集团股份有限公司 一种阿齐霉素在水相直接结晶的方法
CN103159811A (zh) * 2011-12-10 2013-06-19 山东方明药业集团股份有限公司 一种阿齐霉素中间体9a-脱氧-9a-氮杂-9a-高红霉素A的制备方法
WO2013088274A1 (fr) 2011-12-14 2013-06-20 Wockhardt Limited Composition d'azithromycine amorphe anhydre dépourvue de dihydrate d'azithromycine
CN102417531B (zh) * 2011-12-20 2014-06-11 浙江国邦药业有限公司 一种阿奇霉素一水合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020270A (en) * 1974-05-02 1977-04-26 Societa' Farmaceutici Italia S.P.A. L-lyxohex-1-enopyranose derivative
US4219641A (en) * 1979-06-14 1980-08-26 The Upjohn Company Process for preparing erythromycin succinate
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
YU43402B (en) * 1985-03-04 1989-06-30 Pliva Pharm & Chem Works Process for preparation of 11-aza-10-deoxo-10-dihydroeritromycin "a" by using electro-chemical reduction
WO1989002271A1 (fr) 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires

Also Published As

Publication number Publication date
YU132588A (en) 1990-02-28
OA08743A (fr) 1989-03-31
CY1776A (en) 1995-10-20
IL86979A (en) 1992-11-15
LV10624A (lv) 1995-04-20
CS272241B2 (en) 1991-01-15
EP0298650A3 (en) 1989-11-08
US6268489B1 (en) 2001-07-31
DK380688A (da) 1989-01-10
PL157145B1 (en) 1992-04-30
BG47348A3 (bg) 1990-06-15
JPS6438096A (en) 1989-02-08
NO171556B (no) 1992-12-21
DK380688D0 (da) 1988-07-08
PH30953A (en) 1997-12-23
HU211862A9 (en) 1995-12-28
NZ225338A (en) 1990-02-26
ZA884925B (en) 1990-02-28
SG27794G (en) 1994-10-14
PT87933A (pt) 1989-06-30
IN168879B (fr) 1991-06-29
CS489688A2 (en) 1990-03-14
WO1989000576A1 (fr) 1989-01-26
AR243532A1 (es) 1993-08-31
KR900006218B1 (ko) 1990-08-25
UA27040C2 (uk) 2000-02-28
DD271705A5 (de) 1989-09-13
PL273590A1 (en) 1989-03-20
KR890002137A (ko) 1989-04-08
BA98213B1 (bs) 1999-08-02
FI900087A0 (fi) 1990-01-08
AP8800093A0 (en) 1988-05-01
AU604553B2 (en) 1990-12-20
AU1883988A (en) 1989-01-12
IL86979A0 (en) 1988-12-30
IS1540B (is) 1994-01-28
YU45075B (en) 1991-08-31
NO900077L (no) 1990-01-08
FI91263B (fi) 1994-02-28
AP44A (en) 1989-07-27
RO107257B1 (ro) 1993-10-30
IE882108L (en) 1989-01-09
CN1016785B (zh) 1992-05-27
FI91263C (fi) 1994-06-10
NO900077D0 (no) 1990-01-08
CN1030422A (zh) 1989-01-18
IE60354B1 (en) 1994-06-29
EP0298650A2 (fr) 1989-01-11
SI8811325A8 (en) 1996-12-31
JPH0631300B2 (ja) 1994-04-27
EP0298650B1 (fr) 1992-02-05
IS3370A7 (is) 1989-01-10
ES2038756T3 (es) 1993-08-01
DE3868296D1 (de) 1992-03-19
MX12213A (es) 1993-05-01
PT87933B (pt) 1994-09-30
LV10624B (en) 1995-10-20
EG18527A (en) 1993-10-30
FI900087L (fi) 1990-01-08
HK127594A (en) 1994-11-25
DK172573B1 (da) 1999-01-25
NO171556C (no) 1993-03-31
CA1314876C (fr) 1993-03-23
GR3003737T3 (fr) 1993-03-16
MY103744A (en) 1993-09-30
ATE72446T1 (de) 1992-02-15
RU2066324C1 (ru) 1996-09-10

Similar Documents

Publication Publication Date Title
OA08743A (fr) Dihydrate d'azithromycine et son procédé de préparation.
EP0328651A4 (fr) Procede de preparation de supraconducteurs.
FR2656324B1 (fr) Pigment azouique et son procede de preparation.
MA21183A1 (fr) Composes arylpiperazinyl-alkylene-phenyl-heterocycliques et leur procede de preparation.
FR2744652B1 (fr) Catalyseur de type coquille d'oeuf et son procede de preparation
FR2616429B1 (fr) Procede de preparation du 1,2,5,6,9,10-hexabromocyclododecane
KR960003617B1 (en) Crystallized cephem-acid addition salts, and the preparation process thereof
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
FR2510129B1 (fr) Compose d'addition et son procede de preparation
FR2659652B1 (fr) Procede de preparation de n-phenyl benzoquinone-imine.
FR2603589B1 (fr) Compose (phenyldimethylcarbinyl)-silane et son procede de preparation
FR2610924B1 (fr) Procede de preparation d'hydroxybiphenyles
FR2605318B1 (fr) Procede de preparation d'azetidinones.
EP0268678A4 (fr) Nouveaux composes de 5-fluorouridine et procede de preparation.
BE881958A (fr) Element d'armature et son procede de preparation
FR2630741B1 (fr) Procede de preparation d'acryloyloxyethoxymethyl-melamines
FR2602764B1 (fr) Composes dichlorotrifluoromethyltoluenes et procede de preparation de ces composes
FR2571224B1 (fr) Nouvel aliment et son procede de preparation
FR2656219B1 (fr) Composition parfumee et son procede de preparation.
FR2614622B1 (fr) Procede de preparation de polysilanes
RO85568A2 (fr) Derives de 1,1'-o0ybis-aminobenzene clorhydre et procede de preparation
FR2620026B2 (fr) Forme galenique comprenant des microparticules et son procede de preparation
FR2619281B2 (fr) Forme galenique comprenant des microparticules et son procede de preparation
FR2632954B1 (fr) Procede de preparation de pyrimidine-n-oxydes
FR2640264B1 (fr) Procede de preparation de perfluoroalkylthioethers